TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›CSQ
CSQ logo

CSQ

CALAMOS STRATEGIC TOTAL RETURN FUND

Sell
$20.52
▲ +1.13%
$20.52▲ +21.42%
over 1Y
L $16.19H $20.58
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+1.1%
1W+1.5%
1M-0.3%
3M+20.0%
YTD+10.6%
1Y+21.4%
OverviewValuationQualityTimelineFilings
Rating
Sell
Quality
A
Valuation
Fair value
Filings
Clean
Sell
Conviction
Horizon
Medium (3–12mo)

Mixed signals in the latest filings.

CALAMOS STRATEGIC TOTAL RETURN FUND shows limited reported revenue.

On these fundamentals, CSQ screens as SELL on the SEC figures.

Is CSQ a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Bear put spread~60d expiry
  • Long put 20.5 @ ~0.56 est
  • Short put 18.5 @ ~0.06 est
debit $50max +$150max −$50BE 20.00

SELL verdict, defined risk: profits into weakness down to the short strike; max loss is the net debit.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Key statistics

Valuation

Enterprise value$1.40B
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield—
FCF yield—

Quality & risk

ROIC (est.)—
Free cash flow—
Total debt—
Net cash—

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Routine disclosure cadence — no material red flags in recent filings.
  1. DEF 14A Proxy statement2026-05-11
  2. DEF 14A Proxy statement2025-05-12
  3. 8-K Charter / bylaws change2024-05-14
  4. DEF 14A Proxy statement2024-05-14
  5. DEF 14A Proxy statement2023-05-08
  6. DEF 14A Proxy statement2022-05-11
  7. 8-K Charter / bylaws change2021-08-26
  8. DEF 14A Proxy statement2021-05-12
  9. 8-K Charter / bylaws change2021-01-12

Recent filings

all on EDGAR ↗
N-CSRSPeriod ending 2026-04-302026-07-02open ↗40-17GFiling2026-06-29open ↗NPORT-PPeriod ending 2026-04-302026-06-26open ↗SCHEDULE 13G/AFiling2026-05-14open ↗DEF 14APeriod ending 2026-06-232026-05-11open ↗NPORT-PPeriod ending 2026-01-312026-03-31open ↗SCHEDULE 13G/AFiling2026-02-13open ↗N-CENPeriod ending 2025-10-312026-01-13open ↗N-CSRPeriod ending 2025-10-312025-12-29open ↗NPORT-PPeriod ending 2025-10-312025-12-23open ↗SCHEDULE 13G/AFiling2025-11-14open ↗NPORT-PPeriod ending 2025-07-312025-09-29open ↗

Quality score

A
ValueGrowthProfitHealthMom.
Value—
Growth—
Profitability—
Financial health—
MomentumA
16.1952-week20.63
Revenue
—
Net margin
—
ROE
—
P/E
—

SEC fundamentals

Frequently asked

Is CALAMOS STRATEGIC TOTAL RETURN FUND (CSQ) a buy?
CSQ currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Mixed signals in the latest filings.
What is CALAMOS STRATEGIC TOTAL RETURN FUND's quality score?
CSQ scores 89.39854755881984/100 (grade A) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001275214, latest N-CSRS filed 2026-07-02) · EODHD · as of 7/4/2026, 8:39:22 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

Rule-based analysis, generated automatically from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 4:39 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2025-01-30
Herman Thomas E
VP and CFO
Buy11.5K @ $18.39$212K
2025-01-29
Herman Thomas E
VP and CFO
Buy11.7K @ $18.23$213K
2024-09-06
THRIVENT FINANCIAL FOR LUTHERANS
10% owner
Acquired (J)660K @ $25.00$16.5M
2024-09-06
MetLife Investment Management, LLC
10% owner
Disposed (J)160K
2024-09-06
MetLife Investment Management, LLC
10% owner
Disposed (J)1.04M
2024-09-06
MetLife Investment Management, LLC
10% owner
Disposed (J)148K
2024-09-06
MetLife Investment Management, LLC
10% owner
Disposed (J)148K
2023-12-06
Koudounis John S.
Vice President
Sell100.00 @ $14.17$1.42K
2023-12-06
Koudounis John S.
Vice President
Sell1.19K @ $14.17$16.9K
2023-12-06
Koudounis John S.
Vice President
Sell1.73K @ $14.18$24.5K
2023-12-06
Koudounis John S.
Vice President
Sell9.48K @ $14.16$134K
2023-12-06
Koudounis John S.
Vice President
Sell912.00 @ $14.19$12.9K

Dividends

Monthly
Yield (TTM)
7.3%
Annual / share
$1.49
Last ex-date
2026-07-14
Last amount
$0.14
ex 2026-07-14paid 2026-07-21$0.14
ex 2026-06-12paid 2026-06-22$0.12
ex 2026-05-14paid 2026-05-21$0.12
ex 2026-04-14paid 2026-04-21$0.12
ex 2026-03-13paid 2026-03-20$0.12
ex 2026-02-13paid 2026-02-23$0.12

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Congressional trades

all activity →

Disclosed under the STOCK Act

2020-03-10K. Michael ConawaySell$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score89 vs 67
Revenue growth— vs 7.5%
Net margin— vs 10.0%
Return on equity— vs 12.0%
P/E— vs 26.2

News sentiment

EODHD · 3d
Bullish
+0.16
vs typical · 3 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.